Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Molecular Pharmacology
|
February 12, 2017
Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor-Mediated Signaling in Human Amnion and Myometrium
Sung Hye Kim, Oliver Pohl, Andre Chollet, et al.
Journal of the Royal Society, Interface
|
August 4, 2015
Emergence of collective changes in travel direction of starling flocks from individual birds' fluctuations
Alessandro Attanasi, Andrea Cavagna, Lorenzo Del Castello, et al.
Scientific Reports
|
April 10, 2019
Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F<sub>2α</sub>-induced Contractions and Inflammatory Responses in Human Myometrium
Sung Hye Kim, Lucia Riaposova, Hauwa Ahmed, et al.
Scientific Reports
|
March 19, 2021
Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers
Jörg Täubel, Ulrike Lorch, Christopher S Spencer, et al.
Physical Review Letters
|
December 20, 2014
Finite-size scaling as a way to probe near-criticality in natural swarms
Alessandro Attanasi, Andrea Cavagna, Lorenzo Del Castello, et al.
Plos Computational Biology
|
July 25, 2014
Collective behaviour without collective order in wild swarms of midges
Alessandro Attanasi, Andrea Cavagna, Lorenzo Del Castello, et al.
Nature Physics
|
September 30, 2014
Information transfer and behavioural inertia in starling flocks
Alessandro Attanasi, Andrea Cavagna, Lorenzo Del Castello, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 20, 2018
OBE022, an Oral and Selective Prostaglandin F<sub>2</sub><i></i> Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor
Oliver Pohl, André Chollet, Sung Hye Kim, et al.
Biomedicines
|
July 27, 2024
Safety, Tolerability, and EEG-Based Target Engagement of STP1 (PDE3,4 Inhibitor and NKCC1 Antagonist) in a Randomized Clinical Trial in a Subgroup of Patients with ASD
Craig A Erickson, Laura Perez-Cano, Ernest V Pedapati, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Molecular Pharmacology
|
February 12, 2017
Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor-Mediated Signaling in Human Amnion and Myometrium
Sung Hye Kim, Oliver Pohl, Andre Chollet, et al.
Journal of the Royal Society, Interface
|
August 4, 2015
Emergence of collective changes in travel direction of starling flocks from individual birds' fluctuations
Alessandro Attanasi, Andrea Cavagna, Lorenzo Del Castello, et al.
Scientific Reports
|
April 10, 2019
Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F<sub>2α</sub>-induced Contractions and Inflammatory Responses in Human Myometrium
Sung Hye Kim, Lucia Riaposova, Hauwa Ahmed, et al.
Scientific Reports
|
March 19, 2021
Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers
Jörg Täubel, Ulrike Lorch, Christopher S Spencer, et al.
Physical Review Letters
|
December 20, 2014
Finite-size scaling as a way to probe near-criticality in natural swarms
Alessandro Attanasi, Andrea Cavagna, Lorenzo Del Castello, et al.
Plos Computational Biology
|
July 25, 2014
Collective behaviour without collective order in wild swarms of midges
Alessandro Attanasi, Andrea Cavagna, Lorenzo Del Castello, et al.
Nature Physics
|
September 30, 2014
Information transfer and behavioural inertia in starling flocks
Alessandro Attanasi, Andrea Cavagna, Lorenzo Del Castello, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 20, 2018
OBE022, an Oral and Selective Prostaglandin F<sub>2</sub><i></i> Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor
Oliver Pohl, André Chollet, Sung Hye Kim, et al.
Biomedicines
|
July 27, 2024
Safety, Tolerability, and EEG-Based Target Engagement of STP1 (PDE3,4 Inhibitor and NKCC1 Antagonist) in a Randomized Clinical Trial in a Subgroup of Patients with ASD
Craig A Erickson, Laura Perez-Cano, Ernest V Pedapati, et al.
Page
of 3